.WORLD HEAL TH ORGANIZA Tl ON

INTERNATIONAL AGENCY FOR RESEARCH ON CANCER

IARC MONOGRAPHS

ON THE

EV ALVA TION OF CARCINOGENIC

RISKS TO HUMANS

Human Papillomaviruses

VOLUME 64

This publication represents the views and expert opinionsof an IARC W orking Group on the

Evaluation of Carcinogenic Risks to Humans,which met in Lyon,

6-13 June 1995

1995

lARe MONOGRAPHS

ln 1969, the International Agency for Research on Cancer (IARC) initiated a programme onthe evaluation of the carcinogenic risk of chemicals to humans involving the production ofcriticalIy evaluated monographs on individual chemicals. ln 1980 and 1986, the programme wasexpanded to include evaluations of carcinogenic risks associated with exposures to complexmixtures and other agents.

The objective of the programme is to elaborate and publish in the form of monographscritical reviews of data on carcinogenicity for agents to which humans are known to be exposedand on specific exposure situations; to evaluate these data in terms of human risk with the helpof international working groups of experts in chemical carcinogenesis and related fields; and toindicate where additional research efforts are needed.

This project is supported by PHS Grant No. 5-UO 1 CA33 193- 1 4 awarded by the United

States National Cancer lnstitute, Department of Health and Human Services. Additional supporthas been provided since 1986 by the European Commission.

C9lnternational Agency for Research on Cancer 1995

IARC Library Cataloguing in Publication DatalARC Working Group on the Evaluation of Carcinogenic Risks to

Humans (1995 : Lyon, France)Human papillomaviruses : views and expert opinions of an lARC WorkingGroup on the Evaluation of Carcinogenic Risks to Humans which met inLyon, 6-13 June 1995.

(lARC monographs on the evaluation of carcinogenic risks to humans ; 64)1. Carcinogens - toxicity - congres ses 2. Papillomavirus, human - congresses

1. Series

ISBN 92 832 1264 9

lSSN 0250-9555

(NLM Classification: WI)

Publications of the World Health Organization enjoy copyright protection in accordancewith the provisions of Protocol 2 of the Universal Copyright Convention.

AlI rights reserved. Application for rights of reproduction or translation, in part or in toto,should be made to the International Agency for Research on Cancer.

Distributed by the International Agency for Research on Cancer

PRINTED lN THE UNITED KINGDOM